TG Therapeutics’ CFO and CEO Flip Flop: CFO Buys Zero‑Cash Shares, CEO Purchases 622,000 Amid Market Turbulence
TG Therapeutics insiders buy shares amid volatility—CFO and CEO purchases hint at confidence in oncology pipeline and future upside.
2 minutes to read